Bister K - Search Results

1

TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif.

Karagiannidis AI, Bader AG, Hartl M, Bister K. Karagiannidis AI, et al. Among authors: bister k. Virology. 2008 Sep 1;378(2):371-6. doi: 10.1016/j.virol.2008.06.001. Epub 2008 Jul 7. Virology. 2008. PMID: 18603277 Free article.

2

A quail long-term cell culture transformed by a chimeric jun oncogene.

Hartl M, Vogt PK, Bister K. Hartl M, et al. Among authors: bister k. Virology. 1995 Feb 20;207(1):321-6. doi: 10.1006/viro.1995.1086. Virology. 1995. PMID: 7871748 Free article.

3

Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.

Hartl M, Bister K. Hartl M, et al. Among authors: bister k. Oncogene. 1998 Dec 3;17(22):2901-13. doi: 10.1038/sj.onc.1202219. Oncogene. 1998. PMID: 9879996

4

Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.

Bader AG, Hartl M, Bister K. Bader AG, et al. Among authors: bister k. Virology. 2000 Apr 25;270(1):98-110. doi: 10.1006/viro.2000.0222. Virology. 2000. PMID: 10772983 Free article.

5

JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.

Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K. Hartl M, et al. Among authors: bister k. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13601-6. doi: 10.1073/pnas.241451198. Epub 2001 Nov 6. Proc Natl Acad Sci U S A. 2001. PMID: 11698665 Free PMC article.

6

TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).

Bader AG, Schneider ML, Bister K, Hartl M. Bader AG, et al. Among authors: bister k. Oncogene. 2001 Nov 8;20(51):7524-35. doi: 10.1038/sj.onc.1204938. Oncogene. 2001. PMID: 11709724

7

Molecular targets of the oncogenic transcription factor jun.

Hartl M, Bader AG, Bister K. Hartl M, et al. Among authors: bister k. Curr Cancer Drug Targets. 2003 Feb;3(1):41-55. doi: 10.2174/1568009033333781. Curr Cancer Drug Targets. 2003. PMID: 12570660 Review.

8

Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis.

Hartl M, Karagiannidis AI, Bister K. Hartl M, et al. Among authors: bister k. Oncogene. 2006 Jul 6;25(29):4043-55. doi: 10.1038/sj.onc.1209441. Epub 2006 Feb 20. Oncogene. 2006. PMID: 16491116

9

WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential.

Reiter F, Hartl M, Karagiannidis AI, Bister K. Reiter F, et al. Among authors: bister k. Oncogene. 2007 Mar 15;26(12):1769-79. doi: 10.1038/sj.onc.1209975. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964280

10

Cell transformation by the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBP beta-dependent lipocalin gene.

Hartl M, Matt T, Schüler W, Siemeister G, Kontaxis G, Kloiber K, Konrat R, Bister K. Hartl M, et al. Among authors: bister k. J Mol Biol. 2003 Oct 10;333(1):33-46. doi: 10.1016/j.jmb.2003.08.018. J Mol Biol. 2003. PMID: 14516741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters